The Stem Cell Podcast

Ep. 92: “Stem Cells for Arthritis” Featuring Dr. Farshid Guilak

May 23, 2017
Dr. Farshid Guilak, a Washington University orthopaedics professor who develops stem-cell–based therapies for osteoarthritis. He discusses differences between osteoarthritis and rheumatoid arthritis. He explores obesity, diet, and post-traumatic risks to joints. He describes engineering mesenchymal stem cells with CRISPR circuits for targeted anti-inflammatory delivery and local versus systemic treatment strategies.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ADVICE

Use Tailored Exercise As First Line OA Therapy

  • Exercise and movement are first-line treatments for osteoarthritis.
  • Guilak and hosts recommend activity tailored to ability (e.g., pool exercises) to reduce stiffness and pain.
INSIGHT

Diet Quality Impacts Osteoarthritis Severity

  • Diet composition can influence OA independently of weight gain.
  • Guilak's mouse study found omega-3 supplementation reduced OA compared with pro-inflammatory fats despite equal weight gain.
INSIGHT

MSCs Mirror Their Inflammatory Environment

  • Mesenchymal stem cells (MSCs) are environment-sensitive and can amplify inflammation if placed in inflammatory tissue.
  • Guilak found MSCs follow local cues, so unmodified MSC implants can fail in arthritic joints.
Get the Snipd Podcast app to discover more snips from this episode
Get the app